Comments
Loading...
Purple Biotech (PPBT) Forecast
NewsEarningsPurple Biotech (PPBT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPurple Biotech (NASDAQ:PPBT) Stock Quotes, Forecast and News Summary
Purple Biotech Stock (NASDAQ: PPBT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Purple Biotech (PPBT) stock?
You can purchase shares of Purple Biotech (NASDAQ:PPBT) through any online brokerage.
Who are Purple Biotech (PPBT) competitors?
Other companies in Purple Biotech’s space includes: Cingulate (NASDAQ:CING), Kiora Pharmaceuticals (NASDAQ:KPRX), Jaguar Health (NASDAQ:JAGX), Sonoma Pharmaceuticals (NASDAQ:SNOA) and Marinus Pharma (NASDAQ:MRNS).
What is the forecast, or price target, for Purple Biotech (PPBT) stock?
Purple Biotech has a consensus price target of $15.75.
What is the current price for Purple Biotech (PPBT)?
The stock price for Purple Biotech (NASDAQ: PPBT) is $4.2 last updated December 26, 2024 at 11:53 AM EST.
Does Purple Biotech (PPBT) pay a dividend?
There are no upcoming dividends for Purple Biotech.
When is Purple Biotech (NASDAQ:PPBT) reporting earnings?
Purple Biotech’s Q4 earnings are confirmed for Tuesday, March 4, 2025.
Is Purple Biotech (PPBT) going to split?
There is no upcoming split for Purple Biotech.
What sector and industry does Purple Biotech (PPBT) operate in?
Purple Biotech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.